TELA Bio Strengthens MedTech Leadership Ahead of Q3 2025 Results
MALVERN, Pa., November 4, 2025 — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company advancing soft-tissue reconstruction...
AI drug discovery Alzheimer’s Disease Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
MALVERN, Pa., November 4, 2025 — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company advancing soft-tissue reconstruction...
PARIS – October 24, 2025 Sanofi reported a 7.0% sales increase at constant exchange rates (CER) for Q3 2025,...
BURLINGTON, N.C. – October 23, 2025 Labcorp (NYSE: LH), a global leader in laboratory diagnostics, announced it will soon...
RICHMOND, VA – October 17, 2025: BrainBox Solutions has published a major analysis in JAMA Network OPEN from its...
IRVINE, Calif., October 10, 2025 — Johnson & Johnson MedTech has announced the launch of the CORE-VA (Catheter-based Outcomes...
MINNETONKA, Minn. and MIAMI, Fla., Oct. 9, 2025 — Monteris Medical and Symphony Robotics have entered a strategic collaboration...
ST. PAUL, Minn., Oct. 8, 2025 — Envoy Medical, a pioneer in fully implanted hearing device technology, has received...
Stockholm — October 6, 2025. The Nobel Assembly at Karolinska Institutet has awarded the 2025 Nobel Prize in Physiology...
WEST HILLS, Calif., Oct. 8, 2025 — Thermo Fisher Scientific has introduced the Molecular Microscope® Diagnostic System for Lung...
DULUTH, Ga., Oct. 7, 2025 — Bridge to Life Ltd. has received FDA 510(k) clearance for its multi-sourced Belzer...
